Seeing Is Believing
Currently out of the existing stock ratings of Yi Chen, 446 are a BUY (90.65%), 45 are a HOLD (9.15%), 1 are a SELL (0.2%).
Analyst Yi Chen, carries an average stock price target met ratio of 36.91% that have a potential upside of 50.43% achieved within 157 days. Previously, Yi Chen worked at HC WAINWRIGHT.
Yi Chen’s has documented 911 price targets and ratings displayed on 51 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on BLTE, Belite Bio ADR at 15-Sep-2025.
Analyst best performing recommendations are on CELC (CELCUITY LLC).
The best stock recommendation documented was for VERU (VERU) at 12/10/2020. The price target of $8 was fulfilled within 4 days with a profit of $2.03 (34%) receiving and performance score of 85.01.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
1 years 5 months 5 days ago
(03-May-2024)
2/5 (40%)
$13.4 (372.22%)
248
Buy
$15
1 years 6 months 25 days ago
(13-Mar-2024)
1/9 (11.11%)
$11.06 (280.71%)
11
Which stock is Yi Chen is most bullish on?
Which stock is Yi Chen is most reserved on?
What Year was the first public recommendation made by Yi Chen?